At this time, posts about Hyundai Pharm are rapidly increasing on portals and stock communities. Today, foreigners have net sold 33,000 shares of Hyundai Pharm, while institutions have net bought 1,000 shares, according to preliminary data. Hyundai Pharm is known as a manufacturer of health beverages such as Miero Fiber and pharmaceuticals.


As of 11:30 AM on the 15th, Hyundai Pharm's stock price is 7,120 KRW, down 6.44% from the previous day, with a trading volume of 6,015,118 shares, which is about 43.64% of the 5-day average trading volume. On October 14, Hyundai Pharm became a market issue with a 26% surge as a "red medicine" Forbidden Iodine-related stock.


In addition to Hyundai Pharm, posts by investors are also rapidly increasing for Korea Union Pharmaceutical (080720), Hanil Vacuum (123840), and Kwangdong Pharmaceutical (009290).



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing